HB Biotechnology

Latest news and analysis on HB Biotechnology

Equities

Biotech reawakens: policy clarity, breakthrough data and a surge in M&A

Global Biotech is surging as policy fears fade and innovation takes centre stage. Here’s what’s driving the comeback into 2026.
CSL
+10
Charlie Williams
HB Biotechnology
1